These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 28376458)

  • 1. Health Benefits and Cost-Effectiveness of Asymptomatic Screening for Hypertension and High Cholesterol and Aspirin Counseling for Primary Prevention.
    Dehmer SP; Maciosek MV; LaFrance AB; Flottemesch TJ
    Ann Fam Med; 2017 Jan; 15(1):23-36. PubMed ID: 28376458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Screening for proteinuria in US adults: a cost-effectiveness analysis.
    Boulware LE; Jaar BG; Tarver-Carr ME; Brancati FL; Powe NR
    JAMA; 2003 Dec; 290(23):3101-14. PubMed ID: 14679273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Who needs laboratories and who needs statins?: comparative and cost-effectiveness analyses of non-laboratory-based, laboratory-based, and staged primary cardiovascular disease screening guidelines.
    Pandya A; Weinstein MC; Salomon JA; Cutler D; Gaziano TA
    Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):25-32. PubMed ID: 24425701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Updated Priorities Among Effective Clinical Preventive Services.
    Maciosek MV; LaFrance AB; Dehmer SP; McGree DA; Flottemesch TJ; Xu Z; Solberg LI
    Ann Fam Med; 2017 Jan; 15(1):14-22. PubMed ID: 28376457
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Modeling Study for the US Preventive Services Task Force.
    Dehmer SP; O'Keefe LR; Evans CV; Guirguis-Blake JM; Perdue LA; Maciosek MV
    JAMA; 2022 Apr; 327(16):1598-1607. PubMed ID: 35471506
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia.
    Blake GJ; Ridker PM; Kuntz KM
    Am J Med; 2003 Apr; 114(6):485-94. PubMed ID: 12727581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin for the Primary Prevention of Cardiovascular Disease and Colorectal Cancer: A Decision Analysis for the U.S. Preventive Services Task Force.
    Dehmer SP; Maciosek MV; Flottemesch TJ; LaFrance AB; Whitlock EP
    Ann Intern Med; 2016 Jun; 164(12):777-86. PubMed ID: 27064573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a Markov model analysis to assess the cost-effectiveness of statin therapy for the primary prevention of cardiovascular disease in Korea: the Korean Individual-Microsimulation Model for Cardiovascular Health Interventions.
    Kang HY; Ko SK; Liew D
    Clin Ther; 2009 Dec; 31(12):2919-30; discussion 2916-8. PubMed ID: 20110032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of screening and optimal management for diabetes, hypertension, and chronic kidney disease: a modeled analysis.
    Howard K; White S; Salkeld G; McDonald S; Craig JC; Chadban S; Cass A
    Value Health; 2010; 13(2):196-208. PubMed ID: 19878493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis.
    Hassan C; Rex DK; Cooper GS; Zullo A; Launois R; Benamouzig R
    Gut; 2012 Aug; 61(8):1172-9. PubMed ID: 21997545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of the cost-effectiveness of adult influenza vaccination and other preventive services.
    Dabestani NM; Leidner AJ; Seiber EE; Kim H; Graitcer SB; Foppa IM; Bridges CB
    Prev Med; 2019 Sep; 126():105734. PubMed ID: 31152830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary care intervention to reduce alcohol misuse ranking its health impact and cost effectiveness.
    Solberg LI; Maciosek MV; Edwards NM
    Am J Prev Med; 2008 Feb; 34(2):143-152. PubMed ID: 18201645
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease.
    Michaud TL; Abraham J; Jalal H; Luepker RV; Duval S; Hirsch AT
    J Am Heart Assoc; 2015 Dec; 4(12):. PubMed ID: 26702086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Priorities among recommended clinical preventive services.
    Coffield AB; Maciosek MV; McGinnis JM; Harris JR; Caldwell MB; Teutsch SM; Atkins D; Richland JH; Haddix A
    Am J Prev Med; 2001 Jul; 21(1):1-9. PubMed ID: 11418251
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for mild thyroid failure at the periodic health examination: a decision and cost-effectiveness analysis.
    Danese MD; Powe NR; Sawin CT; Ladenson PW
    JAMA; 1996 Jul 24-31; 276(4):285-92. PubMed ID: 8656540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of medical primary prevention strategies to reduce absolute risk of cardiovascular disease in Tanzania: a Markov modelling study.
    Ngalesoni FN; Ruhago GM; Mori AT; Robberstad B; Norheim OF
    BMC Health Serv Res; 2016 May; 16():185. PubMed ID: 27184802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Receipt of Selected Preventive Health Services for Women and Men of Reproductive Age - United States, 2011-2013.
    Pazol K; Robbins CL; Black LI; Ahrens KA; Daniels K; Chandra A; Vahratian A; Gavin LE
    MMWR Surveill Summ; 2017 Oct; 66(20):1-31. PubMed ID: 29073129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the potential return on investment of the proposed UK NHS diabetes prevention programme in different population subgroups: an economic evaluation.
    Thomas C; Sadler S; Breeze P; Squires H; Gillett M; Brennan A
    BMJ Open; 2017 Aug; 7(8):e014953. PubMed ID: 28827235
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 20.